JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Compare Gynaecological Cancer medicines

Compare Gynaecological Cancer medicines

Elahere (mirvetuximab soravtansine-gynx) vs Orserdu (elacestrant)

Jemperli (dostarlimab) vs Elahere (mirvetuximab soravtansine-gynx)

Jemperli (dostarlimab) vs Orserdu (elacestrant)

Jemperli (dostarlimab) vs Tivdak (tisotumab vedotin-tftv)

Jemperli (dostarlimab) vs Vegzelma (bevacizumab-adcd)

Lynparza (olaparib) vs Elahere (mirvetuximab soravtansine-gynx)

Lynparza (olaparib) vs Jemperli (dostarlimab)

Lynparza (olaparib) vs Tivdak (tisotumab vedotin-tftv)

Lynparza (olaparib) vs Vegzelma (bevacizumab-adcd)

Rubraca (rucaparib) vs Elahere (mirvetuximab soravtansine-gynx)

Rubraca (rucaparib) vs Jemperli (dostarlimab)

Rubraca (rucaparib) vs Lynparza (olaparib)

Rubraca (rucaparib) vs Orserdu (elacestrant)

Rubraca (rucaparib) vs Tivdak (tisotumab vedotin-tftv)

Rubraca (rucaparib) vs Vegzelma (bevacizumab-adcd)

Tivdak (tisotumab vedotin-tftv) vs Elahere (mirvetuximab soravtansine-gynx)

Tivdak (tisotumab vedotin-tftv) vs Orserdu (elacestrant)

Tivdak (tisotumab vedotin-tftv) vs Vegzelma (bevacizumab-adcd)

Vegzelma (bevacizumab-adcd) vs Elahere (mirvetuximab soravtansine-gynx)

Vegzelma (bevacizumab-adcd) vs Orserdu (elacestrant)

Zejula (niraparib) vs Elahere (mirvetuximab soravtansine-gynx)

Zejula (niraparib) vs Jemperli (dostarlimab)

Zejula (niraparib) vs Lynparza (olaparib)

Zejula (niraparib) vs Orserdu (elacestrant)

Zejula (niraparib) vs Rubraca (rucaparib)

Zejula (niraparib) vs Tivdak (tisotumab vedotin-tftv)

Zejula (niraparib) vs Vegzelma (bevacizumab-adcd)

LV Latvia 1